Fundraising is picking up among crypto venture funds after two dismal years, as investors hope to profit from the friendly ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...

Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering. About Cantor Equity Partners II, Inc. Cantor Equity Partners II, Inc. is a blank check company sponsored by Cantor ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main driver of the rating is the parent firm's five-year risk-adjusted success ratio of 81%. The measure ...

Monday, Summit Therapeutics plc (NASDAQ:SMMT) received a reiterated Overweight rating from analysts at Cantor Fitzgerald, aligning with the strong analyst consensus of 1.33. The biopharmaceutical ...